Furthermore, they used different murine models of obesity and metabolic syndrome to demonstrate that blocking the RANK–RANKL pathway in the liver significantly improved hepatic insulin sensitivity and normalised blood glucose levels. This evidence concerns the gene TNFSF11 and metabolic syndrome.